Form 4 for XCUR EXICURE, INC.
Accepted 2022-12-19 00:00:00 ET · period of report 2022-12-15 · accession 0000899243-22-038993 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-12-19 | 2022-12-15 | XCUR | CBI USA, Inc. | 10% | P - Purchase | $1.60 | +3.40M | 4.22M | +415% | +$5.44M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-15 | P | A | 3,400,000 | $1.60 | 4,218,299 | D | — | — | (F1) On December 15, 2022, the stockholders of Exicure, Inc. approved the purchase by the Reporting Person of 3,400,000 shares of common stock at a price per share of $1.60 pursuant to the Securities Purchase Agreement, dated September 26, 2022. The purchase is expected to close promptly, but no later than January 20, 2023, subject to satisfaction or waiver of remaining conditions. Notwithstanding that the purchase has not closed yet, the Reporting Person may be deemed to beneficially own these shares due to satisfaction of the stockholder approval condition. |